Finn Therapeutics Revenue

Biotechnology Research • Belfast, N. Ireland, United Kingdom • 1-10 Employees

Finn Therapeutics revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at Finn Therapeutics

Anthony O'Kane

Chief Executive Officer

Company overview

Headquarters	Glendinning House,, 6 Murray Street, Belfast, Northern Ireland BT1 6DN, GB
Website	finntherapeutics.com
NAICS	541714
Keywords	Biotech, Cancer, Antibody Therapeutics, Drug Discovery, Startup, Oncology, Preclinical, Solid Tumour, Anti-Angiogenic, Seed Phase
Employees	1-10

About Finn Therapeutics

Finn Therapeutics are a lean, asset-centric biotech company leveraging years of experience in preclinical and clinical CRO drug development to deliver a novel first-in-class anti-angiogenic therapy for solid tumour treatment.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Finn Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Finn Therapeutics has never raised funding before.

Finn Therapeutics Tech Stack

Discover the technologies and tools that power Finn Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Google Hosted Libraries

CDN

reCAPTCHA

Security

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

Open Graph

Miscellaneous

Font Awesome

Font scripts

Webflow

Page builders

core-js

JavaScript libraries

IONOS

Hosting

jsDelivr

CDN

Google Font API

Font scripts

Frequently asked questions

Finn Therapeutics is located in Belfast, N. Ireland, GB.

Finn Therapeutics generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Finn Therapeutics has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Finn Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Finn Therapeutics

Anthony O'Kane

Chief Executive Officer

4.8

40,000 users